Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INSIGHT: Telaprevir in HCV/HIV Coinfection
NCT01513941Phase 3Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Apr 2012
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of telaprevir in hepatitis C (HCV), sponsored by Janssen Pharmaceutical. Started Apr 2012; status: completed.
02
Drugs
telaprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01513941.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01513941.